176 related articles for article (PubMed ID: 33293826)
1. Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways.
Zhen H; Li G; Zhao P; Zhang Y; Wang J; Yu J; Cao B
Onco Targets Ther; 2020; 13():12325-12339. PubMed ID: 33293826
[TBL] [Abstract][Full Text] [Related]
2. Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis.
Zhen H; Tian J; Li G; Zhao P; Zhang Y; Che J; Cao B
BMC Cancer; 2023 Mar; 23(1):207. PubMed ID: 36870981
[TBL] [Abstract][Full Text] [Related]
3. Traditional Chinese medicine
Wu J; Wang J; Su Q; Ding W; Li T; Yu J; Cao B
Onco Targets Ther; 2018; 11():2685-2698. PubMed ID: 29785118
[TBL] [Abstract][Full Text] [Related]
4. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
5. Apatinib induces endoplasmic reticulum stress-mediated apoptosis and autophagy and potentiates cell sensitivity to paclitaxel via the IRE-1α-AKT-mTOR pathway in esophageal squamous cell carcinoma.
Wang YM; Xu X; Tang J; Sun ZY; Fu YJ; Zhao XJ; Ma XM; Ye Q
Cell Biosci; 2021 Jul; 11(1):124. PubMed ID: 34229754
[TBL] [Abstract][Full Text] [Related]
6. The coordinated effects of Apatinib and Tripterine on the proliferation, invasiveness and apoptosis of human hepatoma Hep3B cells.
Li H; Fan Y; Yang F; Zhao L; Cao B
Oncol Lett; 2018 Jul; 16(1):353-361. PubMed ID: 29928421
[TBL] [Abstract][Full Text] [Related]
7. Apatinib suppresses the Proliferation and Apoptosis of Gastric Cancer Cells via the PI3K/Akt Signaling Pathway.
Jia X; Wen Z; Sun Q; Zhao X; Yang H; Shi X; Xin T
J BUON; 2019; 24(5):1985-1991. PubMed ID: 31786865
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effect of apatinib on HCT-116 cells and its mechanism].
Yin L; Wang J; Huang FC; Zhang YF; Xu N; Wen ZQ; Li WL; Dong J
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Mar; 37(3):367-372. PubMed ID: 28377354
[TBL] [Abstract][Full Text] [Related]
9. Astragalus polysaccharide enhanced antitumor effects of Apatinib in gastric cancer AGS cells by inhibiting AKT signalling pathway.
Wu J; Yu J; Wang J; Zhang C; Shang K; Yao X; Cao B
Biomed Pharmacother; 2018 Apr; 100():176-183. PubMed ID: 29428665
[TBL] [Abstract][Full Text] [Related]
10. Raltitrexed increases radiation sensitivity of esophageal squamous carcinoma cells.
Ding WX; Liu S; Ma JX; Pu J; Wang HJ; Zhang S; Sun XC
Cancer Cell Int; 2019; 19():36. PubMed ID: 30820189
[TBL] [Abstract][Full Text] [Related]
11. Apatinib promotes apoptosis of the SMMC-7721 hepatocellular carcinoma cell line via the PI3K/Akt pathway.
Zhang H; Cao Y; Chen Y; Li G; Yu H
Oncol Lett; 2018 Apr; 15(4):5739-5743. PubMed ID: 29552208
[TBL] [Abstract][Full Text] [Related]
12. Autophagy inhibitor potentiates the antitumor efficacy of apatinib in uterine sarcoma by stimulating PI3K/Akt/mTOR pathway.
Chen S; Yao L
Cancer Chemother Pharmacol; 2021 Aug; 88(2):323-334. PubMed ID: 33978839
[TBL] [Abstract][Full Text] [Related]
13. Metformin Inhibited Growth, Invasion and Metastasis of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo.
Liang F; Wang YG; Wang C
Cell Physiol Biochem; 2018; 51(3):1276-1286. PubMed ID: 30481793
[TBL] [Abstract][Full Text] [Related]
14. Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell.
Huang M; Huang B; Li G; Zeng S
BMC Gastroenterol; 2018 Nov; 18(1):169. PubMed ID: 30400838
[TBL] [Abstract][Full Text] [Related]
15. Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer.
Xie C; Zhou X; Liang C; Li X; Ge M; Chen Y; Yin J; Zhu J; Zhong C
J Exp Clin Cancer Res; 2021 Aug; 40(1):266. PubMed ID: 34429133
[TBL] [Abstract][Full Text] [Related]
16. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
17. Apatinib suppresses tumor progression and enhances cisplatin sensitivity in esophageal cancer via the Akt/β-catenin pathway.
Wei B; Wang Y; Wang J; Cai X; Xu L; Wu J; Wang Y; Liu W; Gu Y; Guo W; Xu Q
Cancer Cell Int; 2020; 20():198. PubMed ID: 32514243
[TBL] [Abstract][Full Text] [Related]
18. Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2.
Gao Z; Shi M; Wang Y; Chen J; Ou Y
Pathol Res Pract; 2019 Jul; 215(7):152422. PubMed ID: 31079851
[TBL] [Abstract][Full Text] [Related]
19. Apatinib induces apoptosis and autophagy via the PI3K/AKT/mTOR and MAPK/ERK signaling pathways in neuroblastoma.
Yu X; Fan H; Jiang X; Zheng W; Yang Y; Jin M; Ma X; Jiang W
Oncol Lett; 2020 Oct; 20(4):52. PubMed ID: 32788939
[TBL] [Abstract][Full Text] [Related]
20. Sporoderm-Removed
Liu G; Zeng T
Integr Cancer Ther; 2021; 20():15347354211062157. PubMed ID: 34841952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
